Literature DB >> 24330555

Overview of regular dialysis treatment in Japan (as of 31 December 2011).

Shigeru Nakai1, Yuzo Watanabe, Ikuto Masakane, Atsushi Wada, Tetsuo Shoji, Takeshi Hasegawa, Hidetomo Nakamoto, Kunihiro Yamagata, Junichiro James Kazama, Naohiko Fujii, Noritomo Itami, Toshio Shinoda, Takashi Shigematsu, Seiji Marubayashi, Osamu Morita, Seiji Hashimoto, Kazuyuki Suzuki, Naoki Kimata, Norio Hanafusa, Kenji Wakai, Takayuki Hamano, Satoshi Ogata, Kenji Tsuchida, Masatomo Taniguchi, Hiroshi Nishi, Kunitoshi Iseki, Yoshiharu Tsubakihara.   

Abstract

A nationwide statistical survey of 4255 dialysis facilities was conducted at the end of 2011. Responses were submitted by 4213 facilities (99.0%). The number of new patients started on dialysis was 38,613 in 2011. Although the number of new patients decreased in 2009 and 2010, it increased in 2011. The number of patients who died each year has been increasing; it was 30,743 in 2011, which exceeded 30,000 for the first time. The number of patients undergoing dialysis has also been increasing every year; it was 304,856 at the end of 2011, which exceeded 300,000 for the first time. The number of dialysis patients per million at the end of 2011 was 2385.4. The crude death rate of dialysis patients in 2011 was 10.2%, which exceeded 10% for the first time in the last 20 years. The mean age of new dialysis patients was 67.84 years and the mean age of the entire dialysis patient population was 66.55 years. The most common primary cause of renal failure among new dialysis patients was diabetic nephropathy (44.3%). Diabetic nephropathy was also the most common primary disease among the entire dialysis patient population (36.7%), exceeding chronic glomerulonephritis (34.8%) which had been the highest until last year. The survey included questions related to the Great East Japan Earthquake, which occurred on 11 March 2011. The results on items associated with the Great East Japan Earthquake were reported separately from this report. The mean uric acid levels of the male and female patients were 7.30 and 7.19 mg/dL, respectively. Certain drugs for hyperuricemia were prescribed for approximately 17% of patients. From the results of the facility survey, the number of patients who underwent peritoneal dialysis (PD) was 9642 and the number of patients who did not undergo PD despite having a peritoneal dialysis catheter was 369. A basic summary of the results on the survey items associated with PD is included in this report and the details were reported separately.
© 2013 The Authors. Therapeutic Apheresis and Dialysis © 2013 International Society for Apheresis.

Entities:  

Keywords:  Combined use; Dialysis patient population; Peritoneal dialysis; Survival rate; Uric acid

Mesh:

Year:  2013        PMID: 24330555     DOI: 10.1111/1744-9987.12147

Source DB:  PubMed          Journal:  Ther Apher Dial        ISSN: 1744-9979            Impact factor:   1.762


  17 in total

Review 1.  Haemodialysis-induced hypoglycaemia and glycaemic disarrays.

Authors:  Masanori Abe; Kamyar Kalantar-Zadeh
Journal:  Nat Rev Nephrol       Date:  2015-04-07       Impact factor: 28.314

2.  Familial Mediterranean Fever developing in a Japanese kidney transplant recipient.

Authors:  Masahiko Yazawa; Makoto Tsujita; Norihiko Goto; Takayuki Yamamoto; Takahisa Hiramitsu; Satoshi Ashimine; Koji Nanmoku; Shunji Narumi; Yoshihiro Tominaga; Yoshihiko Watarai
Journal:  CEN Case Rep       Date:  2015-07-20

3.  Recent analysis of status and outcomes of peritoneal dialysis in the Tokai area of Japan: the second report of the Tokai peritoneal dialysis registry.

Authors:  Masashi Mizuno; Yasuhiko Ito; Yasuhiro Suzuki; Fumiko Sakata; Yosuke Saka; Takeyuki Hiramatsu; Hirofumi Tamai; Makoto Mizutani; Tomohiko Naruse; Norimi Ohashi; Hirotake Kasuga; Hideaki Shimizu; Hisashi Kurata; Kei Kurata; Satoshi Suzuki; Satoko Kido; Yoshikazu Tsuruta; Teppei Matsuoka; Masanobu Horie; Shoichi Maruyama; Seiichi Matsuo
Journal:  Clin Exp Nephrol       Date:  2016-03-07       Impact factor: 2.801

4.  Japanese society for dialysis therapy renal data registry-a window through which we can view the details of Japanese dialysis population.

Authors:  Norio Hanafusa; Shigeru Nakai; Kunitoshi Iseki; Yoshiharu Tsubakihara
Journal:  Kidney Int Suppl (2011)       Date:  2015-06

5.  Thresholds of iron markers for iron deficiency erythropoiesis-finding of the Japanese nationwide dialysis registry.

Authors:  Takayuki Hamano; Naohiko Fujii; Terumasa Hayashi; Hiroyasu Yamamoto; Kunitoshi Iseki; Yoshiharu Tsubakihara
Journal:  Kidney Int Suppl (2011)       Date:  2015-06

6.  Sharing knowledge on dialysis registries worldwide.

Authors:  Kunitoshi Iseki; Allan J Collins
Journal:  Kidney Int Suppl (2011)       Date:  2015-06

7.  Risk factors for maintenance hemodialysis patients undergoing elective and emergency abdominal surgery.

Authors:  Hayato Abe; Ken-ichi Mafune
Journal:  Surg Today       Date:  2014-01-21       Impact factor: 2.549

8.  Factors affecting cerebral oxygenation in hemodialysis patients: cerebral oxygenation associates with pH, hemodialysis duration, serum albumin concentration, and diabetes mellitus.

Authors:  Kiyonori Ito; Susumu Ookawara; Yuichiro Ueda; Sawako Goto; Haruhisa Miyazawa; Hodaka Yamada; Taisuke Kitano; Mitsunobu Shindo; Yoshio Kaku; Keiji Hirai; Masashi Yoshida; Taro Hoshino; Aoi Nabata; Honami Mori; Izumi Yoshida; Masafumi Kakei; Kaoru Tabei
Journal:  PLoS One       Date:  2015-02-23       Impact factor: 3.240

9.  Relationship between kidney function decline and initial risk factors for the progression of diabetic kidney disease: a retrospective analysis of 91 Japanese patients with type 2 diabetes.

Authors:  Toshiharu Ishizuka; Yoshiharu Tokuyama; Atsuya Horie; Yukiko Hatanaka; Sumihiko Sato; Azuma Kanatsuka
Journal:  Diabetol Int       Date:  2016-05-03

10.  Analysis of factors affecting rehospitalization of patients with chronic kidney disease after educational hospitalization.

Authors:  Eiji Kose; Taesong An; Akihiko Kikkawa; Yoshiaki Matsumoto; Hiroyuki Hayashi
Journal:  Clin Pharmacol       Date:  2014-04-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.